Nebenwirkungen · Zyprexa Velotab
ZYPREXA VELOTAB 5 mg orodispersible tablets ZYPREXA VELOTAB 10 mg orodispersible tablets ZYPREXA VELOTAB 15 mg orodispersible tablets ZYPREXA VELOTAB 20 mg orodispersible tablets · Abschnitt 4.8 · PDF-Seite 9
HOS-091064 · Präparat HOS-084185
Very Common Uncommon Rare Not known common Blood and the lymphatic system disorders Eosinophilia Thrombocytopenia11 Leukopenia10 Neutropenia10 Immune system disorders Hypersensitivity11 Metabolism and nutrition disorders Weight gain1 Elevated Development or Hypothermia12 cholesterol levels2,3 exacerbation of Elevated glucose diabetes occasionally levels4 associated with Elevated ketoacidosis or coma, triglyceride levels 2,5 including some fatal Glucosuria cases (see section Increased appetite 4.4) 11 Nervous system disorders Somnolence Dizziness Seizures where in Neuroleptic malignant Akathisia6 most cases a history syndrome (see section Parkinsonism6 of seizures or risk 4.4)12 Dyskinesia6 factors for seizures were reported11 Discontinuation symptoms7, 12
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2024-12-18T15:39:00Z · SHA-256 73fa87b69584a3f5cfea5ab6f6dfbc016489f98f7025ba4306b4e40655f9167f · Passage 03a53424e4885dadfd3564fe69bf9e01df60e36725bc8059f94cce2a7615b799 · Zeichen 1297–2701 im Abschnitt